U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07730541) titled 'Hyperpolarized 13C-MRI and Radiomics in Rectal Cancer' on July 23.
Brief Summary: This study is testing new imaging and analysis methods to improve how doctors predict treatment response in rectal cancer patients receiving chemoradiotherapy. Current MRI scans sometimes miss complete tumor response, which can lead to unnecessary surgery. To address this, researchers will use a special MRI technique called hyperpolarized carbon-13 MRI, along with blood and tissue analysis (metabolomics) and advanced image feature analysis (radiomics). These tools can track how cancer cells use energy and how metabolism changes during treatment.
The s...